Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan;38(1):12-26.
doi: 10.1002/etc.4315. Epub 2018 Dec 20.

High-throughput screening and environmental risk assessment: State of the science and emerging applications

Affiliations
Review

High-throughput screening and environmental risk assessment: State of the science and emerging applications

Daniel L Villeneuve et al. Environ Toxicol Chem. 2019 Jan.

Abstract

In 2007 the United States National Research Council (NRC) published a vision for toxicity testing in the 21st century that emphasized the use of in vitro high-throughput screening (HTS) methods and predictive models as an alternative to in vivo animal testing. In the present study we examine the state of the science of HTS and the progress that has been made in implementing and expanding on the NRC vision, as well as challenges to implementation that remain. Overall, significant progress has been made with regard to the availability of HTS data, aggregation of chemical property and toxicity information into online databases, and the development of various models and frameworks to support extrapolation of HTS data. However, HTS data and associated predictive models have not yet been widely applied in risk assessment. Major barriers include the disconnect between the endpoints measured in HTS assays and the assessment endpoints considered in risk assessments as well as the rapid pace at which new tools and models are evolving in contrast with the slow pace at which regulatory structures change. Nonetheless, there are opportunities for environmental scientists and policymakers alike to take an impactful role in the ongoing development and implementation of the NRC vision. Six specific areas for scientific coordination and/or policy engagement are identified. Environ Toxicol Chem 2019;38:12-26. Published 2018 Wiley Periodicals Inc. on behalf of SETAC. This article is a US government work and, as such, is in the public domain in the United States of America.

Keywords: Adverse outcome pathway; Computational toxicology; Effects-based monitoring; In vitro to in vivo extrapolation; Mixtures; Risk assessment.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Integration of extrapolation models and frameworks required for more effective use of high throughput screening data in environmental risk assessment.
Figure 2:
Figure 2:
Applications of HTS data in (A) screening potential human health risk(s) (Judson et al. 2011) and (B) screening ecological risk to fish as an example.
Figure 3.
Figure 3.
Practical applications of HTS data for risk assessment using the EAR and BEQ approach and how the different approaches relate to each other. ECy(i) = effect concentration at y effect level of compound/sample i; ACC = activity cut-off concentration (often close to EC20(i))

References

    1. Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL. 2010. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Tox Chem. 29: 730–741. - PubMed
    1. Arini A, Mittal K, Dornbos P, Head J, Rutkiewicz J, Basu N. 2017. A cell-free testing platform to screen chemicals of potential neurotoxic concern across twenty vertebrate species. Environ Toxicol Chem. 36:3081–3090. doi: 10.1002/etc.3880. - DOI - PubMed
    1. Armitage JM, Wania F, and Arnot JA. 2014. Application of mass balance models and the chemical activity concept to facilitate the use of in vitro toxicity data for risk assessment. Environ Sci Technol. 48: 9770–9779. doi: 10.1002/etc.2020 - DOI - PubMed
    1. Bell SM, Chang X, Wambaugh JF, Allen DG, Bartels M, Brouwer KLR, Casey WM, Choksi N, Ferguson SS, Fraczkiewicz G, Jarabek AM, Ke A, Lumen A, Lynn SG, Paini A, Price PS, Ring C, Simon TW, Sipes NS, Sprankle CS, Strickland J, Troutman J, Wetmore BA, Kleinstreuer NC. 2018. In vitro to in vivo extrapolation for high throughput prioritization and decision making. Toxicol In Vitro. 47:213–227. - PMC - PubMed
    1. Bessems JG, Loizou G, Krishnan K, Clewell HJ 3rd, Bernasconi C, Bois F, Coecke S, Collnot EM, Diembeck W, Farcal LR, Geraets L, Gundert-Remy U, Kramer N, Küsters G, Leite SB, Pelkonen OR, Schröder K, Testai E, Wilk-Zasadna I, Zaldívar-Comenges JM. 2014. PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop. Regul Toxicol Pharmacol. 68:119–39. doi: 10.1016/j.yrtph.2013.11.008. - DOI - PubMed

Publication types

Substances